Web Analytics Made Easy - StatCounter

Anti Inhibitor Coagulant Complex Tenders

Get complete information related to latest Anti Inhibitor Coagulant Complex Tenders . from India at Classic Tenders. Search the best available tenders from Indian government tenders, domestic Anti Inhibitor Coagulant Complex Tenders , private tenders, online tenders, tender invitation notice, business tender notices, online tenders and bidding Anti Inhibitor Coagulant Complex Tenders .

Filter
Loading....
Loading....
Loading....
Loading....
Loading....

Bid Submission Date Range
Tender Value

corporations/Associations/Others

CTN :45477028 Due date: 06 Jul, 202606 Jul, 2026 13.71 Crore
Tender For corrigendum : e-bid for rate contract cum supply and empanelment of firms for drugs and medicines - fluorouracil inj ip 250 mg/ 5ml [148], mercaptopurine tablets ip 50mg [152], methotrexate tab ip 2.5 mg [154], vincristine injection ip 1mg [159], atropine eye ointment ip 1%[319], ciprofloxacin ophthalmic ointment usp 0.3% [323], dacarbazine injection 500mg ip [529], inj. ganciclovir sodium 500mg (lyophilized powder forreconstitution) [724], recombinant f ix 500 iu with diluent [748], 3rd generation recombinant fviii 250 iuwith diluent [749], gatifloxacin 0.30% and prednisolone acetate 1% ophthalmic suspension[nrd-103], hpmc 0.3%eye drop [nrd-104], chloramphenic ol 1%, polymyxin b sulphate (10000 units) and dexamethasone 0.1% sodium phosphate eye ointment[nrd-123], cabazitaxel injection 60 mg [nrd-167], fludarabine phosphate injection 100mg inj. ip [nrd-237], fludarabine phosphate injection 50mginj. ip [nrd-238], methotrexate 1000 mg inj. ip [nrd-289], inj. methylprednisol one acetate 125 mg i.p. (each vial contains methylprednisol one acetate 125mg) [nrd-292], mitomycin 40 mg inj. ip [nrd-297], omalizumab 150 mg vial inj. [nrd-321], plerixafor 24 mg inj. [nrd-338], recombinant lh 75iu inj. [nrd-351], trabectedin 1 mg inj. [nrd-387], everolimus 5mg tab./cap. [nrd-530], everolimus 10mg tab./cap. [nrd-531], eltrombopag 25mg tablet / capsule [nrd-617], eltrombopag 50mg tablet / capsule [nrd-618], nilotinib 150 mg tablet / capsule [nrd-710], nilotinib 200 mg tablet / capsule [nrd-711], regorafenib 40 mg tab. [nrd-757], tegafur 100mg and uracil 224mg capsule[nrd-794], ulipristal 5mg tab. [nrd-808], black disinfectant fluid (phenyl) as per scheduleo grade iii [398], phenobarbitone inj ip 200mg/ml [420], piperacillin + tazobactum for injection ip 4gm+500mg[468], decitabine 50 mg inj. [nrd-207], levosalbutamol 50mcg. and ipratropium40mcg. mdi [nrd-425], glycopegylated extended half life factor viii 1000 iu

corporations/Associations/Others

CTN :44434778 Due date: 01 Jul, 202601 Jul, 2026 NA
Tender For corrigendum : supply of drugs/medicines - cyclosporine tab/cap -each tab/cap to contain: cyclosporine 50mg., 5-fluorouracil inj-each vial to contain: fluorouracil ip 250mg, cytosine arabinoside inj-each vial to contain: cytosine arabinoside 100mg, packing: 1 vial, tamoxifen tab/cap-each tab/cap to contain: tamoxifen 10mg, bleomycin inj-each vial to contain: bleomycin ip 15iu, vincristine inj-each vial to contain: vincristine ip 1mg, doxorubicin inj-each 5 ml vial to contain: doxorubicin 10mg, methotrexate tab/cap-each tab/cap to contain: methotrexate ip 2.5mg, ifosfamide inj-each vial to contain: ifosfamide 1gm, flutamide tab/cap-each tab/cap to contain: flutamide 250mg, goserelin inj-each pfs to contain: goserelin 3.6mg packing: 1 pfs, vero cell culture rabies vaccine-each dose to contain: purified vero cell culture human rabies vaccine, methotrexate inj-each vial to contain: methotrexate ip 50mg, tamoxifen tab/cap-each tab/cap to contain:tamoxifen 20mg, tetanus vaccine (adsorbed)-each 0.5 ml to contain: tetanus toxoid 5/lfs, capd bag-each bag to contain: capd bag 7.5% of lcodextrin with asymmetrical y connector packing:2 ltr bag, human albumin 20% inj-each bottle to contain: human albumin 20% packing: 100ml bottle, anastrozole tab/cap-each tab/cap to contain: anastrozole 1mg, asparaginase inj-each vial to contain: asparaginase 10000 unit, methotrexate tab/cap-each tab/cap to contain: methotrexate 7.5mg, sorafenib tab/cap-each tab/cap to contain: sorafenib tosylate 200mg, immunoglobulin-each 1 ml solution to contain: active substance (s) human plasma proteins 50 mg, igm 6 mg (12%) , iga 6 mg (12%) igg 38 mg (76%), packing:10ml vial, anti-rabies vaccine-each ml to contain: hrg (rabies immunoglobulin (human)) 150iu, packing:2ml vial/amp/pfs, mycophenolate tab/cap-each tab/cap to contain: mycophenolic acid (as sodium salt) 540mg, leucovorin inj-each vial to contain: leucovorin 50mg, lenalidomide tab/cap-each tab/cap to contain: lenalidomide 5mg, zoledronic acid inj-each vial to contain: zoledronic acid 4mg, octreotide inj-each vial to contains: octreotide 30mg long acting release packing: 1 vial, ceritinib tab/cap-each tab/ hard gelatin cap to contain: ceritinib 150mg, ruxolitinib tab/cap-each tab/cap to contains ruxolitinib 15mg, ruxolitinib tab/cap-each tab/cap contains ruxolitinib 20mg, ruxolitinib tab/cap-each tab/cap contains ruxolitinib 5mg, nivolumab inj-each vial to contain: nivolumab 40mg packing: 1 vial, nivolumab inj-each vial to contain: nivolumab 100mg packing: 1 vial, crizotinib tab/cap-each hard gelatin tab/cap to contain : crizotinib 250mg, carfilzomib inj-each vial to contain: carfilzomib 60mg sterile lypholized powder packing: 1 vial, afatinib tab/cap-each tab/cap to contain: afatinib 20 mg, afatinib tab/cap-each tab/cap to contain: afatinib 30 mg, axitinib tab/cap-each film coated tab/cap to contain: axitinib 5 mg, trabectedin inj-each vial to contain:trabectedin 1mg packing: 1 vial, afatinib tab/cap-each tab/cap to contain: afatinib 40 mg, regorafenib tab/cap-each tab/cap to contain: regorafenib 40mg, recombinant human granulocyte inj-each inj to contain: recombinant human granulocyte macrophage colony stimulating factor (r-hu-gmcsf) 500microgram, degarelix inj-each vial to contain: degarelix 80 mg packing: 1 vial, erlotinib tab/cap-each tab/cap to contain: erlotinib 150 mg, everolimus tab/cap-each tab/cap to contains: everolimus 5 mg, secukinumab inj-each 1 ml to conatin: secukinumab 150mg, sucrose 92.43mg, l- histidine / l- histidine hcl monohydrate 4.656 mg, polysorbate 80 - 0.60mg.packing: 1 vial, tenofovir alafenamide tab/cap-each tab/cap to contains: tenofovir alafenamide 25mg, meningococcal vaccine-each vial to contain: meningococcal group (a,c,y and w135)polysachharide/oligosaccharide diphtheria toxoid conjugate vaccine,0.5 ml vial/pfs, lenvatinib tab/cap-each tab/cap to contains: lenvatinib 4mg, lenvatinib tab/cap-each tab/cap to contains: lenvatinib 10mg, ribociclib tab/cap-each film coated tab/cap

corporations/Associations/Others

CTN :44434788 Due date: 01 Jul, 202601 Jul, 2026 NA
Tender For corrigendum : supply of drugs/medicines - methyldopa tab/cap-each tab/cap to contain: methyldopa 250mg, dopamine inj-each ml to contain: dopamine hcl 40 mg,5ml amp, isoxsuprine inj-each ml to contain: isoxsuprine 5mg packing:2ml vial/amp, flunarizine tab/cap-each tab/cap to contain: flunarizine 10mg, diazepam tab/cap-each tab/cap to contain: diazepam 5mg, imipramine tab/cap-each tab/cap to contain: imipramine 25mg, phenytoin sodium tab/cap-each tab/cap to contain: phenytoin sodium 100mg, dobutamine inj-each vial/amp to contain : dobutamine hcl. eqv. to dobutamine 250mg, ipratropium + salbutamol inhaler-each metered dose to contain: ipratropium i.p.20mcg., salbutamol i.p.100mcg packing:equal to or more than 120 mdi, metoprolol inj-each ml to contain: metoprolol 1mg packing:5ml vial/amp, amiodarone inj-each ml to contain: amiodarone 50mg, packing:3ml amp, vitamin k inj-each ml to contain: phytomenadione 10mg, packing:1ml vial/amp, salmeterol rotacap-each rotacap to contain : salmeterol i.p.50mcg, paediatric cough syp-each 5 ml to contain: promethazine hcl 1.5 mg, pholcodine 1.5 mg (as citrate), packing:60ml bottle, digoxin tab/cap-each tab/cap to contain: digoxin 0.25 mg, isoxsuprine tab/cap-each tab/cap to contain: isoxsuprine hcl 10 mg, haemostatic tab/cap-each tab/cap to contain: citrus bioflavonoid compound 150 mg, ascorbic acid 75 mg, menadione (vit.k) 0.66 mg, ferrous gluconate 67 mg, tribasic calcium phosp. 144.43 mg., nimodipine tab/cap-each tab/cap to contain: nimodipine 30 mg, sodium valproate syp-each 5ml to contain: sodium valproate i.p. 200 mg packing:100ml bottle, sodium valproate tab/cap -each tab/cap to contain: sodium valproate 200mg., levodopa & carbidopa tab/cap-each tab/cap to contain: levodopa 250 mg, carbidopa 25 mg, cough syp-each 5 ml to contain: methdilazine 2.5 mg , amm. chloride 100 mg, sodium citrate 50 mg, packing:115ml bottle, anti hemophillic inj - each vial to contain:anti hemophillic factor viii (non-recombinant)/ monoclonal purified - 250 iu, turbuhaler/inhaler -each metered dose to contain: budesonide 160 mcg, formoterol fumarate dihydrate 4.5 mcg, lactose monohydrate 730 mcg.(equal to or more than 60 doses), adenosine inj-each 2ml to contain: adenosine 6mg, packing:2ml amp, nicorandil sustained release tab/cap-each sustained release tab/cap to contain: nicorandil 20mg, fondaparinux sodium inj-each pfs to contain: fondaparinux sodium 2.5mg, vitamin k inj-each amp to contain: vitamin k ip 1.0 mg, packing:0.5ml amp, lorazepam tab/cap-each tab/cap to contain: lorazepam 1mg, phenobarbitone syp-each 5ml to contain: phenobarbitone 20mg, packing:60ml bottle, triclofos syp-each 5ml to contain: triclofos sodium bp 500mg, packing:30ml bottle, piracetam syp-each 5ml to contain: piracetam 500mg packing:100ml bottle, sumatriptan tab/cap-each tab/cap to contain: sumatriptan 50mg, zolpidem tartrate er tab/cap-each er tab/cap to contain: zolpidem tartrate 12.5 mg, tenecteplase 40mg inj-each vial to contain: tenecteplase 40mg, factor eight bypassing activity - containing : factor eight bypassing activity, anti-inhibitor-coagulant complex. 500 iu/u., recombinant anti hemophillic factor-viii -containing : recombinant anti hemophillic factor-viii 250 iu, ranolazine 500mg tab/cap each plain/sr/cr/dr/er/mrtab/cap to contain: ranolazine 500mg, labetalol inj-each ml to contain: labetalol hydrochloride 5mg, packing:4ml amp, bupripion er tab/cap -each er tab/cap to contain: bupripion 150mg, phenytoin sodium syp-each ml to contain: phenytoin sodium 25mg packing:100ml bottle, perindopril erbumine 8mg, amlodipine besilate equivalent to amlodipine 5mg excipients q.s. tab/cap-each uncoated tab/cap to contain:perindopril erbumine 8mg,amlodipine besilate equivalent to amlodipine 5mg excipients q.s., perindopril erbumine 8mg, indapamide 2.5mg excipients q.s. scored tab/cap -each uncoated scored tab/cap to contain: perindopril erbumine 8mg, indapamide 2.5mg excipients q.s., budesonide + levosalbutamol respule:each amp to con

corporations/Associations/Others

CTN :45087762 Due date: 19 May, 202619 May, 2026 8.46 Crore
Tender For short term e-bid for rate contract cum supply and empanelment of firms for drugs and medicines - fluorouracil inj ip 250 mg/ 5ml [148], mercaptopurine tablets ip 50 mg [152], methotrexate tab ip 2.5 mg [154], vincristine injection ip 1 mg [159], atropine eye ointment ip 1% [319], ciprofloxacin ophthalmic ointment usp 0.3% [323], dacarbazine injection 500 mg ip [529], inj. ganciclovir sodium 500mg (lyophilized powder for reconstitution) [724], recombinant f ix 500 iu with diluent [748], 3rd generation recombinant f viii 250 iu with diluent [749], brinozolamide 1% w/v and brimonidine tartrate 0.2% w/v ophthalmic suspension [nrd-98], gatifloxacin 0.30% and prednisolone acetate 1% ophthalmic suspension [nrd-103], hpmc 0.3% eye drop [nrd-104], proparacaine 0.5% w/v eye drop usp [nrd-114], voriconazole 1 % w/v (lyophilized) 30mg eye drop [nrd-119], chloramphenicol 1%, polymyxin b sulphate (10000 units) and dexamethasone 0.1% sodium phosphate eye ointment [nrd-123], cabazitaxel injection 60 mg [nrd-167], carmustine 100 mg inj. ip [nrd-175], fludarabine phosphate injection 100mg inj. ip [nrd-237], fludarabine phosphate injection 50mg inj. ip [nrd-238], methotrexate 1000 mg inj. ip [nrd-289], inj. methylprednisolone acetate 125 mg i.p. (each vial contains methylprednisolone acetate 125 mg) [nrd-292], mitomycin 40 mg inj. ip [nrd-297], omalizumab 150 mg vial inj. [nrd-321], plerixafor 24 mg inj. [nrd-338], rasburicase 1.5 mg inj. [nrd-347], recombinant lh 75iu inj. [nrd-351], trabectedin 1 mg inj. [nrd- 387], everolimus 5mg tab./cap. [nrd-530], everolimus 10mg tab./cap. [nrd-531], eltrombopag 25mg tablet / capsule [nrd-617], eltrombopag 50mg tablet / capsule [nrd-618], nilotinib 150 mg tablet / capsule [nrd-710], nilotinib 200 mg tablet / capsule [nrd-711], regorafenib 40 mg tab. [nrd-757], tegafur 100mg and uracil 224mg capsule [nrd-794], ulipristal 5mg tab. [nrd-808], glycopegylated extended half life factor viii 1000 iu
 Loading, Please wait...

Connect us via What's Up